Literature DB >> 33661977

Flow Assisted Mutation Enrichment (FAME): A highly efficacious and efficient method to enrich Double Knockouts (DKO) after gene editing.

Michael Hansen1, Xiaopin Cai2, Sara Bowen3, David A Largaespada2,4, Ming V Li1,5.   

Abstract

Gene editing has become an essential tool for interrogation of gene function in biomedical research and is also a promising approach for gene therapy. Despite recent progresses, the gene-editing procedure is still a tedious process involving manually isolating large number of single cell colonies to screen for desired mutations. For diploid eukaryotic cells, there is the additional challenge to inactivate both alleles for genes-of-interest, i.e., generating double knockouts (DKOs), for the desired phenotypes or therapeutic effects. In this report, we present a novel method based on Fluorescence Assisted Cell Sorting (FACS) to enrich for DKO cells, using a cell surface marker β2-microglobulin (B2M) as a basis for negative selection. This method significantly increased percentage of DKOs in isolated cells after gene editing, and in the meantime, significantly improve the efficiency of workflow by automating colony isolation. It would greatly facilitate future biomedical research including potential gene/cell therapies.

Entities:  

Year:  2021        PMID: 33661977      PMCID: PMC7932066          DOI: 10.1371/journal.pone.0247375

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  18 in total

1.  Marker-free coselection for CRISPR-driven genome editing in human cells.

Authors:  Daniel Agudelo; Alexis Duringer; Lusiné Bozoyan; Caroline C Huard; Sophie Carter; Jeremy Loehr; Dafni Synodinou; Mathieu Drouin; Jayme Salsman; Graham Dellaire; Josée Laganière; Yannick Doyon
Journal:  Nat Methods       Date:  2017-04-17       Impact factor: 28.547

2.  Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells.

Authors:  B H Koller; P Marrack; J W Kappler; O Smithies
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

3.  Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition.

Authors:  Jiangtao Ren; Xiaojun Liu; Chongyun Fang; Shuguang Jiang; Carl H June; Yangbing Zhao
Journal:  Clin Cancer Res       Date:  2016-11-04       Impact factor: 12.531

4.  Genome engineering using the CRISPR-Cas9 system.

Authors:  F Ann Ran; Patrick D Hsu; Jason Wright; Vineeta Agarwala; David A Scott; Feng Zhang
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

Review 5.  MYC on the path to cancer.

Authors:  Chi V Dang
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

6.  HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.

Authors:  María A Garrido; Teresa Rodriguez; Svitlana Zinchenko; Isabel Maleno; Francisco Ruiz-Cabello; Ángel Concha; Nicolás Olea; Federico Garrido; Natalia Aptsiauri
Journal:  Immunogenetics       Date:  2018-08-25       Impact factor: 2.846

7.  Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.

Authors:  Dachun Wang; Yuan Quan; Qing Yan; John E Morales; Rick A Wetsel
Journal:  Stem Cells Transl Med       Date:  2015-08-18       Impact factor: 6.940

8.  Simple and efficient methods for enrichment and isolation of endonuclease modified cells.

Authors:  Branden S Moriarity; Eric P Rahrmann; Dominic A Beckmann; Caitlin B Conboy; Adrienne L Watson; Daniel F Carlson; Erik R Olson; Kendra A Hyland; Scott C Fahrenkrug; R Scott McIvor; David A Largaespada
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

Review 9.  RNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi?

Authors:  Unnikrishnan Unniyampurath; Rajendra Pilankatta; Manoj N Krishnan
Journal:  Int J Mol Sci       Date:  2016-02-26       Impact factor: 5.923

10.  Ectopic expression of Zmiz1 induces cutaneous squamous cell malignancies in a mouse model of cancer.

Authors:  Laura M Rogers; Jesse D Riordan; Brian L Swick; David K Meyerholz; Adam J Dupuy
Journal:  J Invest Dermatol       Date:  2013-02-20       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.